Simple Method to Estimate Mean Heart Dose From Hodgkin Lymphoma Radiation Therapy According to Simulation X-Rays
Creators
- 1. Department of Psychosocial Research, Epidemiology, and Biostatistics, The Netherlands Cancer Institute, Amsterdam (Netherlands)
- 2. Oxford Cancer Centre, Oxford University Hospitals NHS Trust, Oxford (United Kingdom)
- 3. Clinical Trial Service Unit, University of Oxford, Oxford (United Kingdom)
- 4. Department of Radiology, The Netherlands Cancer Institute, Amsterdam (Netherlands)
- 5. Department of Radiation Oncology, Leiden University Medical Center, Leiden (Netherlands)
- 6. Department of Radiation Oncology, Erasmus MC Cancer Center, Rotterdam (Netherlands)
- 7. Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam (Netherlands)
Description
Purpose: To describe a new method to estimate the mean heart dose for Hodgkin lymphoma patients treated several decades ago, using delineation of the heart on radiation therapy simulation X-rays. Mean heart dose is an important predictor for late cardiovascular complications after Hodgkin lymphoma (HL) treatment. For patients treated before the era of computed tomography (CT)-based radiotherapy planning, retrospective estimation of radiation dose to the heart can be labor intensive. Methods and Materials: Patients for whom cardiac radiation doses had previously been estimated by reconstruction of individual treatments on representative CT data sets were selected at random from a case–control study of 5-year Hodgkin lymphoma survivors (n=289). For 42 patients, cardiac contours were outlined on each patient's simulation X-ray by 4 different raters, and the mean heart dose was estimated as the percentage of the cardiac contour within the radiation field multiplied by the prescribed mediastinal dose and divided by a correction factor obtained by comparison with individual CT-based dosimetry. Results: According to the simulation X-ray method, the medians of the mean heart doses obtained from the cardiac contours outlined by the 4 raters were 30 Gy, 30 Gy, 31 Gy, and 31 Gy, respectively, following prescribed mediastinal doses of 25-42 Gy. The absolute-agreement intraclass correlation coefficient was 0.93 (95% confidence interval 0.85-0.97), indicating excellent agreement. Mean heart dose was 30.4 Gy with the simulation X-ray method, versus 30.2 Gy with the representative CT-based dosimetry, and the between-method absolute-agreement intraclass correlation coefficient was 0.87 (95% confidence interval 0.80-0.95), indicating good agreement between the two methods. Conclusion: Estimating mean heart dose from radiation therapy simulation X-rays is reproducible and fast, takes individual anatomy into account, and yields results comparable to the labor-intensive representative CT-based method. This simpler method may produce a meaningful measure of mean heart dose for use in studies of late cardiac complications
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2015.02.019Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2015.02.019;
- PII
- S0360-3016(15)00186-8;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 92
- Journal Issue
- 1
- Journal Page Range
- p. 153-160
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 47028282
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANATOMY; COMPARATIVE EVALUATIONS; COMPUTERIZED TOMOGRAPHY; DOSIMETRY; HEART; LYMPHOMAS; PATIENTS; PLANNING; RADIATION DOSES; RADIOTHERAPY; SIMULATION; X RADIATION
- Descriptors DEC
- BIOLOGY; BODY; CARDIOVASCULAR SYSTEM; DIAGNOSTIC TECHNIQUES; DISEASES; DOSES; ELECTROMAGNETIC RADIATION; EVALUATION; IMMUNE SYSTEM DISEASES; IONIZING RADIATIONS; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; ORGANS; RADIATIONS; RADIOLOGY; THERAPY; TOMOGRAPHY
Optional Information
- Copyright
- Copyright (c) 2015 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.